Your browser doesn't support javascript.
Ensuring a high-quality and resilient supply chain of essential medications means paying more.
Mattingly, T Joseph; Conti, Rena M.
  • Mattingly TJ; Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland.
  • Conti RM; Institute for Health System Innovation and Policy and Questrom School of Business, Boston University.
J Manag Care Spec Pharm ; 28(5): 573-576, 2022 May.
Article in English | MEDLINE | ID: covidwho-1863467
ABSTRACT
DISCLOSURES Dr Mattingly reports consulting fees from Arnold Ventures, Pharmaceutical Research and Manufacturers of America, and research support from the US Food and Drug Administration unrelated to this article.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Costs / Commerce Limits: Humans Language: English Journal: J Manag Care Spec Pharm Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Costs / Commerce Limits: Humans Language: English Journal: J Manag Care Spec Pharm Year: 2022 Document Type: Article